SequelSEC

OSR Health, Inc. OSRH

Surgical & Medical Instruments & Apparatus · CIK 0001840425 · Fiscal year ends 1231

Revenue
$1.81M
Fiscal year ended 2026-06-30
Operating income
-$16.89M
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$7.70MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-12-31
Float per share$0.23Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue2.6×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity0.1×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-12-31, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Surgical & Medical Instruments & Apparatus filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Current ratio0.16x6th
Gross margin20.4%9th
Revenue YoY growth-17.7%10th
Operating margin-631.0%13th
R&D / revenue11.0%45th

OSR Health, Inc. (OSRH) reported revenue of $1.81M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from OSR Health, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

OSR Health, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$1.81M
Cost of revenue$1.17M
Gross profit$638.32K
Operating income-$16.89M
Net incomeUnavailable
Research & development$382.55K
Weighted-average diluted sharesUnavailable
Pretax income-$17.63M
Income tax expense-$2.72M
Diluted EPSUnavailable
Selling, general & administrative$17.53M
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

OSR Health, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$1.50M
Total assets$166.62M
Current assets$2.87M
Total liabilities$41.71M
Current liabilities$15.73M
Total equity incl. NCI$124.91M
Temporary (mezzanine) equityUnavailable
Inventory$594.29K
Accounts receivable$188.80K
Goodwill$29.19M
Long-term debt$271.35K
Accounts payableUnavailable

Cash flow

OSR Health, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow-$7.20M
Capital expendituresUnavailable
Investing cash flow-$3.38M
Financing cash flow$10.74M
Net change in cashUnavailable
Stock-based compensationUnavailable
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortizationUnavailable

Derived

OSR Health, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flowUnavailable
Gross margin35.3%
Operating margin-933.7%
FCF marginUnavailable
SBC / revenueUnavailable
Current ratio0.18x
Revenue YoY growth-50.2%
Net marginUnavailable
R&D / revenue21.1%
CapEx / revenueUnavailable
Long-term debt / equity0.00x
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open OSRH in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-14View SEC filing
10-Q · Filed 2026-05-13View SEC filing
10-K · Filed 2026-03-31View SEC filing
10-Q · Filed 2025-11-12View SEC filing
10-Q · Filed 2025-08-14View SEC filing
10-Q · Filed 2025-05-20View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.